Dynamic Changes and Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Patients with Non-Drug-Resistant and Multi-Drug-Resistant Pulmonary Tuberculosis

GAO Yu; WU Qianhong; HU Ping; WANG Li; GUO Le

doi:10.14009/j.issn.1672-2124.2022.06.006

您当前的位置：

首页 >

文章列表页 >

Dynamic Changes and Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Patients with Non-Drug-Resistant and Multi-Drug-Resistant Pulmonary Tuberculosis

更新时间：2022-10-08

- Dynamic Changes and Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Patients with Non-Drug-Resistant and Multi-Drug-Resistant Pulmonary Tuberculosis
- Vol. 22, Issue 6, Pages: 661-663(2022)
- 作者机构：
  
  1. 陕西省结核病防治院/陕西省第五人民医院内四科
  2. 陕西省结核病防治院/陕西省第五人民医院影像中心
  3. 陕西省结核病防治院/陕西省第五人民医院内五科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2022.06.006
  CLC： R521
- Published：2022，
扫描看全文
GAO Yu, WU Qianhong, HU Ping, et al. Dynamic Changes and Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Patients with Non-Drug-Resistant and Multi-Drug-Resistant Pulmonary Tuberculosis. [J]. 22(6):661-663(2022)
DOI：

GAO Yu, WU Qianhong, HU Ping, et al. Dynamic Changes and Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Patients with Non-Drug-Resistant and Multi-Drug-Resistant Pulmonary Tuberculosis. [J]. 22(6):661-663(2022) DOI： 10.14009/j.issn.1672-2124.2022.06.006.

摘要

目的：探讨非耐药和耐多药肺结核患者外周血T淋巴细胞亚群动态变化及临床意义。方法：选取2020年1月至2021年6月该院收治的97例肺结核患者为研究对象，均进行耐药性检测，根据检测结果将患者分为耐多药组和非耐药组，两组患者均检测并对比外周血T淋巴细胞CD3

、CD4

、CD8

、CD4

/CD8

和外周血Th1、Th2、Th17细胞亚群水平。耐多药组和非耐药组患者均进行抗结核治疗3个月，评价抗结核治疗效果并复查外周血T淋巴细胞亚群水平。结果：治疗前，耐多药组患者外周血T淋巴细胞CD3

、CD4

和CD4

/CD8

水平显著低于非耐药组，差异均有统计学意义（P

0.05）;两组患者CD8

水平比较，差异无统计学意义（P

0.05）;耐多药组患者外周血Th1、Th2水平显著低于非耐药组，外周血Th17水平显著高于非耐药组，差异均有统计学意义（P

0.05）。非耐药组患者抗结核治疗预后良好率为77.59%（45/58）

显著高于耐多药组的35.90%（14/39）

差异有统计学意义（P

0.05）。与治疗前比较，非耐药组患者治疗后CD3

、CD4

和CD4

/CD8

水平均显著升高，差异均有统计学意义（P

0.05）;而耐多药组患者治疗后CD3

、CD4

和CD4

/CD8

水平与本组治疗前比较，差异均无统计学意义（P

0.05）。与治疗前比较，非耐药组患者治疗后Th1、Th2水平显著升高，Th17水平显著降低，差异均有统计学意义（P

0.05）;而耐药性组患者治疗后Th1、Th2和Th17水平与本组治疗前比较，差异均无统计学意义（P

0.05）。结论：肺结核患者存在明显的免疫功能受损状态，且耐多药肺结核患者的免疫功能受损状态更严重；结核分枝杆菌的耐药性会影响肺结核患者体内的免疫功能及抗结核治疗效果。

Abstract

OBJECTIVE: To probe into the dynamic changes and clinical significance of peripheral blood T lymphocyte subsets in patients with non-drug-resistant and multi-drug-resistant pulmonary tuberculosis. METHODS: Totally 97 patients with pulmonary tuberculosis admitted into the hospital from Jan. 2020 to Jun. 2021 were extracted as the research objects. All patients were tested for drug resistance. According to the results

all patients were divided into multi-drug resistance group and non-drug resistance group. Peripheral blood T lymphocyte CD3

CD4

CD8

CD4

/CD8

ratio and peripheral blood Th1

Th2

Th17 cell subsets were detected and compared between two groups. Both the multi-drug-resistance group and the non-drug-resistance group received anti-tuberculosis treatment for 3 months

and the anti-tuberculosis treatment effect was evaluated and the levels of peripheral blood T lymphocyte subsets were re-examined. RESULTS: Before treatment

the peripheral blood T lymphocyte CD3

CD4

CD8

CD4

/CD8

ratio in the multi-drug-resistance group was significantly lower than that in the non-drug-resistance group

with statistically significant difference（P

0.05）

and there was no significant difference in the level of CD8

between two groups（P

0.05）. Peripheral blood Th1 and Th2 in the multi-drug-resistance group were significantly lower than those in the non-drug-resistance group

and peripheral blood Th17 was significantly higher than that in the non-drug-resistance group

with statistically significant difference（P

0.05）. The good prognosis rate of non-drug-resistance group was 77.59%（45/58）

significantly higher than that of multi-drug-resistance group（35.90%

14/39）

the difference was statistically significant（P

0.05）. Compared with before treatment

CD3

CD4

/CD8

ratio in non-drug-resistance group increased significantly after treatment

with statistically significant difference（P

0.05）. There were no significant differences in CD3

CD4

/CD8

ratio in the multi-drug-resistance group after treatment compared with those before treatment（P

0.05）. Compared with before treatment

Th1 and Th2 in non-drug-resistance group increased significantly and Th17 decreased significantly after treatment

with statistically significant difference（P

0.05）. However

there were no significant differences in Th1

Th2 and Th17 in the multi-drug-resistance group after treatment compared with those before treatment（P

0.05）. CONCLUSIONS: Patients with pulmonary tuberculosis have significantly impaired immune status

which is more severe in patients with multi-drug-resistant pulmonary tuberculosis; drug resistance of Mycobacterium tuberculosis affects the immune status and the efficacy of anti-tuberculosis treatment in patients with pulmonary tuberculosis.

关键词

肺结核耐药性T淋巴细胞亚群

Keywords

Pulmonary tuberculosisDrug resistanceT lymphocyte subsets

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research on Drug Resistance, Risk Factors and Efficacy of Drug Combination of Fluoroquinolones in Patients with Pulmonary Tuberculosis

Systematic Review of Efficacy and Safety of Linezolid in the Treatment of Drug-Resistant Tuberculosis

Expression of T Lymphocyte Subsets in Peripheral Blood of Patients with AIDS Complicated with PCP and Its Correlation with Therapeutic Effect of Compound Sulfamethoxazole

Clinical Study of Kangfuxin Liquid in Adjuvant Anti-Tuberculous Chemotherapy for Intestinal Tuberculosis

Distribution of Pathogenic Bacteria and Drug Sensitivity Results in Sputum Samples of 1 636 Patients with Lower Respiratory Tract Infection

Related Author

WU Kunliang

ZHENG Youbin

CHEN Qihuang

FENG Xiong

CHEN Di

LI Xingang

WANG Weina

DONG Yiwen

Related Institution

Dept.of Infectious Diseases,Haikou Hospital Affiliated to Xiangya School of Medicine of CSU

Dept.of Tropical Medicine,the second Affiliated Hospital of Hainan Medical University

Dept.of Tuberculosis,the 900th Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army

Dept. of Pharmacy, Beijing Friendship Hospital Affiliated to Capital Medical University

Dept. of Pharmacy, Beijing Hospital

⁰